The Sherwin-Williams Company
The Sherwin-Williams Company (SHW) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for The Sherwin-Williams Company (SHW), covering cash flow, earnings, and balance sheets.
The Sherwin-Williams Company (SHW) Income Statement & Financial Overview
View the income breakdown for The Sherwin-Williams Company SHW across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.31B | $5.30B | $6.16B | $6.27B |
| Cost of Revenue | $2.75B | $2.72B | $3.13B | $3.21B |
| Gross Profit | $2.56B | $2.57B | $3.03B | $3.06B |
| Gross Profit Ratio | $0.48 | $0.49 | $0.49 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.80B | $1.88B | $1.89B | $1.85B |
| Operating Expenses | $1.80B | $1.88B | $3.03B | $1.83B |
| Total Costs & Expenses | $4.54B | $4.61B | $5.03B | $5.04B |
| Interest Income | -$600000.00 | -$1.40M | $2.60M | $900000.00 |
| Interest Expense | $103.80M | $98.50M | $107.00M | $115.20M |
| Depreciation & Amortization | $153.20M | $161.90M | $155.60M | $153.30M |
| EBITDA | $917.70M | $876.00M | $1.29B | $1.39B |
| EBITDA Ratio | $0.17 | $0.17 | $0.21 | $0.22 |
| Operating Income | $765.30M | $673.50M | $1.13B | $1.23B |
| Operating Income Ratio | $0.14 | $0.13 | $0.18 | $0.20 |
| Other Income/Expenses (Net) | -$112.30M | -$57.90M | -$108.30M | -$58.40M |
| Income Before Tax | $653.00M | $615.60M | $1.02B | $1.17B |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.17 | $0.19 |
| Income Tax Expense | $149.10M | $135.50M | $216.60M | $283.50M |
| Net Income | $503.90M | $480.10M | $806.20M | $889.90M |
| Net Income Ratio | $0.09 | $0.09 | $0.13 | $0.14 |
| EPS | $2.02 | $1.92 | $3.22 | $3.55 |
| Diluted EPS | $2.00 | $1.90 | $3.18 | $3.50 |
| Weighted Avg Shares Outstanding | $249.40M | $252.68M | $250.60M | $251.00M |
| Weighted Avg Shares Outstanding (Diluted) | $252.50M | $254.10M | $253.90M | $254.20M |
The company's financials show resilient growth, with revenue advancing from $6.27B in Q2 2024 to $5.31B in Q1 2025. Gross profit remained healthy with margins at 48% in Q1 2025 compared to 49% in Q2 2024. Operating income hit $765.30M last quarter, sustaining a consistent 14% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $917.70M. Net income rose to $503.90M, while earnings per share reached $2.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan